Indian CMO will make Roche blockbusters – InPharm
InPharmIndian CMO will make Roche blockbustersInPharmMeanwhile, a separate report in the Economic Times has suggested that the deal could also be extended to cover Roche's non-Hodgkin's lymphoma therapy MabThera/Rituxan (rituximab). The deal is…